Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis

Area of Science:

• Dermatology
• Pulmonology
• Pharmacology

Background:

• Pirfenidone is a crucial medication for treating idiopathic pulmonary fibrosis (IPF).
• Photosensitivity is a known potential side effect of various medications.
• Idiopathic pulmonary fibrosis affects lung tissue, leading to scarring and breathing difficulties.

Observation:

• This is the first reported case of pirfenidone-induced photoleukomelanoderma.
• A male predominance was observed in patients experiencing photosensitivity.
• The action spectrum for this reaction appears to include both ultraviolet (UV)-A and UV-B radiation.

Findings:

• Pirfenidone can cause a distinct skin reaction characterized by light-induced leukoderma (light patches) and melanoderma (dark patches).
• The photosensitivity reaction is more prevalent in males.
• The reaction is triggered by exposure to a broad spectrum of ultraviolet light.

Implications:

• Clinicians prescribing pirfenidone must counsel patients on the high risk of photosensitivity.
• Comprehensive photoprotection strategies should be implemented before initiating pirfenidone therapy.
• Increased awareness of this adverse effect is crucial for managing patients with idiopathic pulmonary fibrosis.